Abstract:Background: In the past few decades, with the abuse of antibiotics, bacterial resistance has enhanced constantly. More and more super species of bacteria, which are seriously threatening human health, have been discovered. Developing novel antibacterial agents to overcome the drug-resistance is an urgent duty. We all know that blocking the information-transfer of bacterial DNA and RNA is one of the effective ways to inhibit bacterial growth. Therefore, as the indispensable enzyme for DNA replication and transcription, DNA gyrase is one of the important targets for bacterial inhibitors. Accordingly, many inhibitors of DNA gyrase have also been developed. Methods: In this review, to highlight the recent progress in DNA gyrase inhibitors, the study in this field over the past three years (2017-2019) was summarized and organized based on their backbones or core moieties. Both of the subunits of DNA gyrase were taken into consideration. Results: These DNA gyrase inhibitors have been classified based on their backbones or core moieties. After the comparison of the divided 14 categories, we could achieve some clues for future modification. In particular, we found that benzodiazepines and naphthalene heterocycles were the most common structures in the drug design. On the other hand, isopropyl and cyclopropyl have also been used in drug design, which provides more inspiration for the investigations. Except for GSK2140944, which has entered the phase III clinical trial stage, other compounds here were not fully promulgated with their optimal pharmacokinetic activity. Conclusion: We briefly summed up the current situation and future challenges on this topic. Through the discussion of the design strategies and drug effect, we hope that this review can provide a focused direction for future researches.

Inhibition of the gyrA promoter by transcription-coupled DNA supercoiling in Escherichia coli

Friend or Foe: Protein Inhibitors of DNA Gyrase

Single-molecule imaging of DNA gyrase activity in living Escherichia coli

Experimental and Molecular Docking Studies of Cyclic Diphenyl Phosphonates as DNA Gyrase Inhibitors for Fluoroquinolone-Resistant Pathogens

In Silico Study of the Potential Inhibitory Effects on Escherichia coli DNA Gyrase of Some Hypothetical Fluoroquinolone–Tetracycline Hybrids

Structural Basis of Transcription Inhibition by CBR Hydroxamidines and CBR Pyrazoles

Temporospatial control of topoisomerases by essential cellular processes

Novel and Structurally Diversified Bacterial DNA Gyrase Inhibitors Discovered through a Fluorescence-Based High-Throughput Screening Assay

Structural and Mechanistic Basis for the Inhibition of Escherichia Coli RNA Polymerase by T7 Gp2

Examination of bacterial inhibition using a catalytic DNA.

Overexpression of mfpA Gene Increases Ciprofloxacin Resistance in Mycobacterium smegmatis

Role of DNA Double-Strand Break Formation in Gyrase Inhibitor-Mediated Killing of Nonreplicating Persistent Mycobacterium tuberculosis in Caseum

The site‐specific recombination system regulating expression of the Type 1 fimbrial subunit gene of Escherichia coli is sensitive to changes in DNA supercoiling

A Homogeneous, High-Throughput Fluorescence Anisotropy-Based DNA Supercoiling Assay

The acidic C-terminal tail of DNA Gyrase of Salmonella enterica serovar Typhi controls DNA relaxation in an acidic environment

Crp-Cyclic Amp Dependent Inhibition of the Xylene-Responsive Sigma(54)-Promoter Pu in Escherichia Coli

Recent Progress in Small Molecular Inhibitors of DNA Gyrase

Is Simultaneous Binding to DNA and Gyrase Important for the Antibacterial Activity of Cystobactamids?

Direct Observation of Positive Supercoils Introduced by Reverse Gyrase Through Atomic Force Microscopy

Macromolecular crowding potently stimulates DNA supercoiling activity of Mycobacterium tuberculosis DNA gyrase

T7 Phage Protein Gp2 Inhibits The Escherichia Coli Rna Polymerase By Antagonizing Stable Dna Strand Separation Near The Transcription Start Site